Establishment Labs Holdings Inc. ESTA · Stock Open Establishment Labs Holdings Inc. in new tab
Analyst price targets
Recent rating changes, newest first
Establishment Labs Holdings Inc. Analysis (ESTA)
Is Establishment Labs Holdings Inc. a good investment? Establishment Labs Holdings Inc. (ESTA) is currently trading at 57.88 USD. Market analysts have a consensus price target of 102.44 USD. This suggests a potential upside from current levels.
Earnings Schedule: Establishment Labs Holdings Inc. is expected to release its next earnings report on Nov. 4, 2026. The market consensus estimate for Forward EPS is 0.06.
Investor FAQ
Does Establishment Labs Holdings Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Establishment Labs Holdings Inc.?
Establishment Labs Holdings Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 4, 2026. The company currently has a trailing EPS of -1.30.
Company Profile
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.
Community Discussion